Hodges Capital Management Inc. Artivion, Inc. Transaction History

Hodges Capital Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$22.45 - $27.09 $3.57 Million - $4.31 Million	-159,220 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.98 - $30.8 $430,618 - $510,510	-16,575 Reduced 9.43%	159,220 $4.32 Million
Q2 2019 Aug 22, 2019	BUY	$27.55 - $32.39 $1.27 Million - $1.5 Million	46,230 Added 35.68%	175,795 $5.26 Million
Q1 2019 Apr 15, 2019	BUY	$25.85 - $30.47 $3.35 Million - $3.95 Million	129,565 New	129,565 $3.78 Million

173

35.8M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.27B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.